Forte Biosciences, INC. (FBRX) SEC Filings — 2024
26 SEC filings for Forte Biosciences, INC. (FBRX) in 2024.
Filings
- Forte Biosciences Files Definitive Proxy Statement — DEF 14A · Dec 31, 2024
- Forte Biosciences, INC. SC 13G/A Filing — SC 13G/A · Dec 6, 2024
- Forte Biosciences Files 8-K Report — 8-K · Dec 3, 2024
- Forte Biosciences Files 8-K: Material Agreement & Equity Sales — 8-K · Nov 20, 2024
- Forte Biosciences, INC. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Forte Biosciences Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Forte Biosciences Names New Director and CMO — 8-K · Sep 20, 2024
- Forte Biosciences Files 8-K on Security Holder Rights — 8-K · Aug 30, 2024
- Forte Biosciences Appoints New Officers, Director Departs — 8-K · Aug 22, 2024
- Forte Biosciences Files 8-K — 8-K · Aug 14, 2024
- Forte Biosciences Q2 2024 Update — 10-Q · Aug 14, 2024
- Forte Biosciences Files Definitive Proxy Statement — DEF 14A · Jul 30, 2024
- Camac Fund Ups Stake in Forte Biosciences — SC 13D/A · Jun 17, 2024
- Forte Biosciences Files 8-K for Material Agreement — 8-K · Jun 14, 2024
- Forte Biosciences Files 8-K Report — 8-K · May 13, 2024
- Forte Biosciences, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
- Forte Biosciences, Inc. Files 10-K/A Amendment — 10-K/A · Apr 29, 2024
- Forte Biosciences Files 8-K — 8-K · Mar 18, 2024
- Forte Biosciences, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 18, 2024
- Forte Biosciences Amends 8-K Filing on Security Holder Vote — 8-K/A · Feb 16, 2024
- Forte Biosciences, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Forte Biosciences, INC. SC 13G Filing — SC 13G · Feb 14, 2024
- Forte Biosciences, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- BML Investment Partners Amends Forte Bio Stake (Amendment 5) — SC 13D/A · Jan 11, 2024
- Funicular Funds Amends Forte Bio Stake, Ma-Weaver Leads — SC 13D/A · Jan 9, 2024
- Camac Fund Amends Forte Bio 13D, Adds ATG Capital Contact — SC 13D/A · Jan 5, 2024